Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Go back to Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

Repligen (RGEN) Tops Q1 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

May 9, 2019 7:37 AM EDT

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.28, $0.07 better than the analyst estimate of $0.21. Revenue for the quarter came in at $60.6 million versus the consensus estimate of $53.62 million.

Revenue increased by 35% year-over-year, and 37% organically, to a record $60.6 millionGAAP income from operations increased 510 bps to 18.4% of revenueAdjusted (non-GAAP) income from operations increased 500 bps to 25.7% of revenueGAAP fully-diluted EPS increased to $0.17 compared to $0.08 for the first quarter of 2018Adjusted (non-GAAP) fully-diluted EPS increased to $0.28 compared to $0.17 for the first quarter of 2018

Tony J. Hunt, President and Chief Executive... More